quinaprilat has been researched along with cimetidine in 4 studies
| Studies (quinaprilat) | Trials (quinaprilat) | Recent Studies (post-2010) (quinaprilat) | Studies (cimetidine) | Trials (cimetidine) | Recent Studies (post-2010) (cimetidine) |
|---|---|---|---|---|---|
| 92 | 23 | 4 | 9,473 | 1,687 | 377 |
| Protein | Taxonomy | quinaprilat (IC50) | cimetidine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.59 | |
| Solute carrier family 22 member 2 | Mus musculus (house mouse) | 8 | |
| Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 0.82 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.1742 | |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 1.02 | |
| Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 0.82 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 3.0333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cetnarowski, AB; Ferry, JJ; Horvath, AM; Sedman, AJ; Thomas, RW | 1 |
4 other study(ies) available for quinaprilat and cimetidine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite (CI-928).
Topics: Adult; Antihypertensive Agents; Cimetidine; Drug Interactions; Female; Humans; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1988 |